The Diabetology Unit provides care to IRCCS ISMETT patients undergoing surgical and highly-specialized procedures. The Unit focuses on the diagnosis and treatment of patients with type 1 and type 2 diabetes (developed after an organ transplant and, in general, after highly-specialized surgery) following standard and dedicated protocols.

Special emphasis is placed on patient education with a multidisciplinary approach that also involves the Dietary and the Clinical Psychology services. Patients at high cardiovascular risk or cardiac decompensation are co-managed with the Cardiology Unit.

The Diabetology Unit relies on the latest pharmacological treatments and manages the technological tools necessary for personalized treatments, offering patients all therapeutic strategies, including isolated pancreas or combined kidney-pancreas transplantation. Patients eligible for a pancreas transplant undergo a multidisciplinary medical and surgical evaluation, and are followed before, during, and after the transplant.

The Unit is committed to clinical research on diabetes and metabolism, develops experimental protocols, and is involved in multicenter projects. The Unit is also supported by the experience of Dr. Camillo Ricordi, President of the IRCCS ISMETT board of directors, and director of the Diabetes Research Institute at the University of Miami Diabetes Research Institute, a world-class center with broad research experience in the field of diabetes and pancreatic islet transplantation.